Related Experiment Video

Updated: Apr 26, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.0K

Updated recommendations on the use of meningococcal vaccines

    Pediatrics
    |July 30, 2014
    PubMed

    Insights

    This policy statement updates American Academy of Pediatrics (AAP) recommendations for meningococcal vaccines in children and adolescents, incorporating new infant vaccines and CDC guidelines. It ensures optimal protection against meningococcal disease.

    Area of Science:

    • Pediatrics
    • Immunization
    • Vaccinology

    Background:

    • The last American Academy of Pediatrics (AAP) policy on meningococcal vaccines was in 2011.
    • Two new meningococcal conjugate vaccines (Hib-MenCY-TT and MenACWY-CRM) are now licensed for infant use.
    • The Centers for Disease Control and Prevention (CDC) released updated recommendations in 2013.

    Purpose of the Study:

    • To update the AAP policy statement on meningococcal vaccine use in children and adolescents.
    • To incorporate newly licensed infant vaccines into recommendations.
    • To align with but also update CDC recommendations.

    Main Methods:

    • Policy statement review and update.
    • Incorporation of new vaccine licensure data.
    • Consideration of updated CDC guidelines.

    Main Results:

    • The CDC recommendations were published before the licensure of MenACWY-CRM for infant use.
    • This statement provides updated AAP recommendations.
    • It addresses the use of meningococcal vaccines in pediatric populations.

    Conclusions:

    • Updated recommendations are necessary due to new vaccine approvals and evolving guidelines.
    • The policy statement provides current guidance for pediatric meningococcal immunization.
    • It aims to enhance protection against meningococcal disease in children and adolescents.

    Keywords:
    adolescent vaccinesimmunization schedulemeningococcal vaccinemeningococcus

    More Related Videos

    Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

    Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

    Published on: May 19, 2020

    3.0K
    Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

    Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

    Published on: May 7, 2020

    7.9K

    Related Concept Videos

    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    9
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
    10
    Viral Meningitis01:18

    Viral Meningitis

    Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
    189
    Vaccinations01:51

    Vaccinations

    Overview
    43.9K
    Cranial and Spinal Meninges01:19

    Cranial and Spinal Meninges

    The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
    Cranial Meninges
    These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
    4.5K
    Vaccines01:21

    Vaccines

    Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
    86